Allay Therapeutics
PrivateLast Round
Debt
Jun 5, 2025
Total Funding Raised
$167.5M
Company Overview
Allay Therapeutics is a biotechnology company that develops sustained analgesic products aimed at enhancing post-surgical pain management and recovery for patients and healthcare providers.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Allay Therapeutics Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Allay Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Jun 5, 2025 | ||||
| Series C | Sep 15, 2021 | ||||
| Series B | Feb 12, 2019 |
Allay Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Temasek | Series C |
| Vertex Ventures HC | Debt, Series C |
| Arboretum Ventures | Debt, Series C |
| New Enterprise Associates (NEA) | Debt, Series C, Series B |
| Lightstone Ventures | Series B, Seed, Series A, Debt |
| ClavystBio | Debt |
| EDBI | Debt |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 5, 2025
$58M round completed.
- Jun 5, 2025
Anselm Tan of ClavystBio joins the board.
Allay Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Allay Therapeutics's valuation, stock price, and market status.